Company registration number 03017511 (England and Wales)
DALBYS NURSERIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH REGISTRAR
DALBYS NURSERIES LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
DALBYS NURSERIES LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2026
31 January 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
4
247,579
294,479
Current assets
Stocks
157,652
143,641
Debtors
5
124,675
117,014
Cash at bank and in hand
2,593,081
2,178,751
2,875,408
2,439,406
Creditors: amounts falling due within one year
6
(376,221)
(308,701)
Net current assets
2,499,187
2,130,705
Total assets less current liabilities
2,746,766
2,425,184
Provisions for liabilities
(33,598)
(44,212)
Net assets
2,713,168
2,380,972
Capital and reserves
Called up share capital
45,000
45,000
Profit and loss reserves
2,668,168
2,335,972
Total equity
2,713,168
2,380,972
DALBYS NURSERIES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 JANUARY 2026
31 January 2026
- 2 -

For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 3 June 2026 and are signed on its behalf by:
Mr S Dalby
Director
Company registration number 03017511 (England and Wales)
DALBYS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
1
Accounting policies
Company information

Dalbys Nurseries Limited is a private company limited by shares incorporated in England and Wales. The registered office is Manor Farm, Warthill, York, YO19 5XP.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Buildings
2% straight line
Implements and machinery
15% reducing balance
Fixtures and fittings
25% straight line
Motor vehicles
25% reducing balance
Greenhouses
10% straight line
Caravan and fixtures
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

DALBYS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 4 -
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

DALBYS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

DALBYS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 6 -
1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.13

Employee benefit trust

The company operates a discretionary trust for the benefit of the families of all its officers and employees (the Employment Benefit Trust or EBT). In accordance with FRS 102 "Intermediate payment arrangements" the company includes the assets and liabilities of the EBT on its balance sheet to the extent that it considers that is will retain any economic benefit from the assets of the EBT or will have control of the rights or other access to those present economic benefits.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
12
12
DALBYS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 7 -
4
Tangible fixed assets
Buildings
Implements and machinery
Fixtures and fittings
Motor vehicles
Greenhouses
Caravan and fixtures
Total
£
£
£
£
£
£
£
Cost
At 1 February 2025
106,470
227,835
12,432
329,159
289,435
4,500
969,831
Additions
-
0
4,710
5,912
-
0
-
0
-
0
10,622
At 31 January 2026
106,470
232,545
18,344
329,159
289,435
4,500
980,453
Depreciation and impairment
At 1 February 2025
28,369
204,470
7,014
176,702
254,297
4,500
675,352
Depreciation charged in the year
2,129
4,211
4,112
38,114
8,956
-
0
57,522
At 31 January 2026
30,498
208,681
11,126
214,816
263,253
4,500
732,874
Carrying amount
At 31 January 2026
75,972
23,864
7,218
114,343
26,182
-
0
247,579
At 31 January 2025
78,101
23,365
5,418
152,457
35,138
-
0
294,479
DALBYS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 8 -
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
75,605
68,028
Other debtors
49,070
48,986
124,675
117,014
6
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
114,513
124,183
Taxation and social security
204,535
129,952
Other creditors
57,173
54,566
376,221
308,701
2026-01-312025-02-01falsefalsefalse03 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMrs P DalbyMr J DalbyMr S DalbyMr S Dalby030175112025-02-012026-01-31030175112026-01-31030175112025-01-3103017511core:LandBuildingscore:OwnedOrFreeholdAssets2026-01-3103017511core:PlantMachinery2026-01-3103017511core:FurnitureFittings2026-01-3103017511core:MotorVehicles2026-01-3103017511core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2026-01-3103017511core:Non-standardPPEClass2ComponentTotalPropertyPlantEquipment2026-01-3103017511core:LandBuildingscore:OwnedOrFreeholdAssets2025-01-3103017511core:PlantMachinery2025-01-3103017511core:FurnitureFittings2025-01-3103017511core:MotorVehicles2025-01-3103017511core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2025-01-3103017511core:Non-standardPPEClass2ComponentTotalPropertyPlantEquipment2025-01-3103017511core:CurrentFinancialInstrumentscore:WithinOneYear2026-01-3103017511core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-3103017511core:CurrentFinancialInstruments2026-01-3103017511core:CurrentFinancialInstruments2025-01-3103017511core:ShareCapital2026-01-3103017511core:ShareCapital2025-01-3103017511core:RetainedEarningsAccumulatedLosses2026-01-3103017511core:RetainedEarningsAccumulatedLosses2025-01-3103017511bus:CompanySecretaryDirector12025-02-012026-01-3103017511core:LandBuildingscore:OwnedOrFreeholdAssets2025-02-012026-01-3103017511core:PlantMachinery2025-02-012026-01-3103017511core:FurnitureFittings2025-02-012026-01-3103017511core:MotorVehicles2025-02-012026-01-3103017511core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2025-02-012026-01-3103017511core:Non-standardPPEClass2ComponentTotalPropertyPlantEquipment2025-02-012026-01-31030175112024-02-012025-01-3103017511core:LandBuildingscore:OwnedOrFreeholdAssets2025-01-3103017511core:PlantMachinery2025-01-3103017511core:FurnitureFittings2025-01-3103017511core:MotorVehicles2025-01-3103017511core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2025-01-3103017511core:Non-standardPPEClass2ComponentTotalPropertyPlantEquipment2025-01-31030175112025-01-3103017511bus:PrivateLimitedCompanyLtd2025-02-012026-01-3103017511bus:SmallCompaniesRegimeForAccounts2025-02-012026-01-3103017511bus:FRS1022025-02-012026-01-3103017511bus:AuditExemptWithAccountantsReport2025-02-012026-01-3103017511bus:Director12025-02-012026-01-3103017511bus:Director22025-02-012026-01-3103017511bus:Director32025-02-012026-01-3103017511bus:CompanySecretary12025-02-012026-01-3103017511bus:FullAccounts2025-02-012026-01-31xbrli:purexbrli:sharesiso4217:GBP